Hepatitis B virus (HBV) reactivation (HBV-R) and hepatitis related to HBV-R are well-
recognized complications that occur in patients who have undergone cytotoxic …

Background Our aim was to investigate dynamic changes in hepatitis B virus (HBV) surface
antibody (HBsAb) titer and the associated risk of HBV reactivation and clinical course in …

Objective: To describe and quantify the incidence and morbidity of hepatitis B reactivation
(HBVr) secondary to pharmaceutical agents (eg, rituximab, tumor necrosis factor inhibitors …

Abstract Aims Hepatitis B virus (HBV) infection is a worldwide distributing viral disease.
Hepatitis caused by HBV reactivation may progress to chronic illness and associated with …

Background The change in hepatitis B surface antibody (anti-HBs) titers after chemotherapy
(CT) in patients with hematological malignancy, affecting factors, and its clinical implications …

Objective Patients with resolved hepatitis B virus (HBV) infection are at risk of HBV
reactivation during treatment for hematological malignancies. We conducted a systematic …

Aim: Patients with resolved hepatitis B virus (HBV) infection are at risk of HBV reactivation
during treatment for hematologic malignancies. We aim to conduct a meta-analysis of the …

ARAŞTIRMA Page 1 Multipl Miyelom ve Lenfomalı Kemoterapi Alan Hastalarda Hepatit B
Virüsü Reaktivasyonu ve Aşı Başarısı ile İlişkili Faktörler Factors Associated with Hepatitis B …

Objective In our study, we aimed to assess the differences in antibody titers against hepatitis
B virus (HBV) prior and post leukemia therapy in children with acute lymphoblastic leukemia …

Background: Our aim was to investigate dynamic changes in hepatitis B virus (HBV) surface
antibody (HBsAb) titer and the associated risk of HBV reactivation and clinical course in …